[HTML][HTML] Dual antiplatelet therapy after PCI in patients at high bleeding risk
Background The appropriate duration of dual antiplatelet therapy in patients at high risk for
bleeding after the implantation of a drug-eluting coronary stent remains unclear. Methods …
bleeding after the implantation of a drug-eluting coronary stent remains unclear. Methods …
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
M Valgimigli, E Frigoli, D Heg, J Tijssen, P Jüni… - New England Journal …, 2021 - cir.nii.ac.jp
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[PDF][PDF] Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
M Valgimigli, E Frigoli, D Heg, J Tijssen, P Jüni… - N Engl J …, 2021 - otamendi.com.ar
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk Page 1 The new england
journal of medicine n engl j med 385;18 nejm.org October 28, 2021 1643 established in 1812 …
journal of medicine n engl j med 385;18 nejm.org October 28, 2021 1643 established in 1812 …
Dual antiplatelet therapy after PCI in patients at high bleeding risk
MASTER DAPT Investigators - New England Journal of …, 2021 - pure.fujita-hu.ac.jp
Background: The appropriate duration of dual antiplatelet therapy in patients at high risk for
bleeding after the implantation of a drug-eluting coronary stent remains unclear. Methods …
bleeding after the implantation of a drug-eluting coronary stent remains unclear. Methods …
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
M Valgimigli, E Frigoli, D Heg, J Tijssen, P Juni… - 2021 - documentserver.uhasselt.be
BACKGROUND The appropriate duration of dual antiplatelet therapy in patients at high risk
for bleeding after the implantation of a drug-eluting coronary stent remains unclear …
for bleeding after the implantation of a drug-eluting coronary stent remains unclear …
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
M Valgimigli, E Frigoli, D Heg, J Tijssen, P Jüni… - 2021 - pubmed.ncbi.nlm.nih.gov
Background The appropriate duration of dual antiplatelet therapy in patients at high risk for
bleeding after the implantation of a drug-eluting coronary stent remains unclear. Methods …
bleeding after the implantation of a drug-eluting coronary stent remains unclear. Methods …
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
MASTER DAPT Investigators - The New …, 2021 - research-repository.uwa.edu.au
BACKGROUND: The appropriate duration of dual antiplatelet therapy in patients at high risk
for bleeding after the implantation of a drug-eluting coronary stent remains unclear …
for bleeding after the implantation of a drug-eluting coronary stent remains unclear …
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
M Valgimigli, E Frigoli, DH Heg, J Tijssen… - New England journal …, 2021 - boris.unibe.ch
BACKGROUND The appropriate duration of dual antiplatelet therapy in patients at high risk
for bleeding after the implantation of a drug-eluting coronary stent remains unclear …
for bleeding after the implantation of a drug-eluting coronary stent remains unclear …
[PDF][PDF] Dual antiplatelet therapy after PCI in patients at high bleeding risk
M Valgimigli - tis.terumo.com
MASTER DAPT (MAnagement of high bleeding risk patients post bioresorbable polymer
coated STEnt implantation with an abbReviated versus prolonged DAPT regimen) was a …
coated STEnt implantation with an abbReviated versus prolonged DAPT regimen) was a …
[PDF][PDF] Dual antiplatelet therapy after PCI in patients at high bleeding risk
M Valgimigli - terumo-europe.com
MASTER DAPT (MAnagement of high bleeding risk patients post bioresorbable polymer
coated STEnt implantation with an abbReviated versus prolonged DAPT regimen) was a …
coated STEnt implantation with an abbReviated versus prolonged DAPT regimen) was a …